Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Latest news on JOHNSON & JOHNSON
11:41aJOHNSON & JOHNSON : Janssen to Acquire Investigational Bermekimab from XBiotech
PU
10:38aXBiotech Shares Jump After Selling Bermekimab to Janssen
DJ
08:17aJOHNSON & JOHNSON : Janssen Pharmaceutical Companies - IMBRUVICA Combination The..
AQ
08:17aJOHNSON & JOHNSON : Janssen Announces BCMA CAR-T Therapy JNJ-4528 Granted U.S. F..
AQ
06:52aJOHNSON & JOHNSON : Announces Commitment to Support Republic of Rwanda's Prepare..
AQ
06:41aXBIOTECH : Sells Bermekimad to Janssen Biotech
DJ
12/06JOHNSON & JOHNSON : Janssen Says Investigational Treatment for Myeloma Gets FDA ..
DJ
12/06AMGEN : Says FDA Approves Avsola for Same Indications as Remicade
DJ
12/05JOHNSON & JOHNSON : Change in Directors or Principal Officers (form 8-K)
AQ
12/05JOHNSON & JOHNSON : Names Hubert Joly, Executive Chairman of Best Buy and Mark A..
PU
12/05JOHNSON & JOHNSON : C O R R E C T I O N -- Johnson & Johnson/
PR
12/03Johnson & Johnson says new tests show no asbestos in Johnson's Baby Powder
RE
12/03J&J : Testing Confirms No Asbestos in Baby Powder
DJ
12/03JOHNSON & JOHNSON : Company Investigation Confirms No Asbestos in Johnson's Baby..
PR
12/03MOVING BENADRYL BEHIND THE COUNTER D : pharmacists
AQ
12/03JOHNSON & JOHNSON : Announces Winners of Champions of Science Storytelling Chall..
AQ
11/27Opioid Makers Hit With Criminal Probe -- WSJ
DJ
11/27JOHNSON & JOHNSON : Drugmakers, distributors facing federal opioid probe
AQ
11/26Opioid Makers, Distributors Fall Following WSJ Report on Federal Probe
DJ
11/26Federal Prosecutors Launch Criminal Probe of Opioid Makers, Distributors
DJ
11/25JOHNSON & JOHNSON : Ex-dividend day for
FA
11/22The Best-Managed Companies of 2019 -- and How -2-
DJ
11/22The Best-Managed Companies of 2019 -- and How They Got That Way -- Journal Re..
DJ
11/21JOHNSON & JOHNSON : Australian judge finds Johnson & Johnson 'negligent' in vagi..
AQ
11/21JOHNSON & JOHNSON : Oklahoma attorney general to appeal judge's opioid ruling
AQ
11/21JOHNSON & JOHNSON : Women win landmark class action against Johnson & Johnson in..
AQ
11/19GENMAB : EC Approves Expanded Darzalex Use in Multiple Myeloma
DJ
11/18JOHNSON & JOHNSON : Janssen Leverages Wearable Technology to Reimagine Clinical ..
AQ
11/18J&J Rushed to Test Safety of Baby Powder -- WSJ
DJ
11/17JOHNSON & JOHNSON : J&J Rapidly Tested Its Baby Powder After Asbestos Finding --..
DJ
11/16Johnson & Johnson Opioid Verdict Cut -- WSJ
DJ
11/15Johnson & Johnson's Oklahoma Opioid Penalty Reduced to $465 Million
DJ
11/15JOHNSON & JOHNSON : Oklahoma judge reduces J&J order in opioid lawsuit by $107M
AQ
11/15JOHNSON & JOHNSON : Oklahoma judge reduces amount Johnson & Johnson must pay sta..
AQ
11/13JOHNSON & JOHNSON : CARIBBEAN-POPULATION-International Population Summit opens i..
AQ
11/12JOHNSON & JOHNSON : Defendants in opioid case say politico's input not needed
AQ
11/12JOHNSON & JOHNSON : TREMFYA a First-in-Class IL-23 p19 Subunit Inhibitor, Meets ..
AQ
11/12JOHNSON & JOHNSON : Janssen Pharmaceutical - TREMFYA, a First-in-Class IL-23 p19..
AQ
11/11J&J'S JANSSEN : Tremfya Meets Main Endpoints in Psoriatic Arthritis Studies
DJ
11/11JOHNSON & JOHNSON : New Analysis from Landmark CREDENCE Study Shows the Efficacy..
AQ
11/11JOHNSON & JOHNSON : Janssen Announces Submission of Supplemental New Drug Applic..
AQ
11/08JOHNSON & JOHNSON : J&J's Janssen Gets Health Canada OK for Expanded Imbruvica U..
DJ
11/08JOHNSON & JOHNSON : J&J's Janssen Seeks FDA OK for Expanded Imbruvica Use
DJ
11/08JOHNSON & JOHNSON : Announces Submission of European Marketing Authorisation App..
AQ
11/07JOHNSON & JOHNSON : New York judge sets opioid crisis trial for January
AQ
11/01JOHNSON & JOHNSON : Announces Donation of up to 500,000 Regimens of Janssen's In..
AQ
11/01JOHNSON & JOHNSON : Janssen Presenting Data from its Expanding Rheumatology Port..
AQ
10/29JOHNSON & JOHNSON : J&J Says Suspect Baby Powder Is Asbestos-Free -- Update
DJ
10/29JOHNSON & JOHNSON : J&J says new tests find no asbestos in recalled baby powder
AQ
10/29JOHNSON & JOHNSON : J&J Says Suspect Baby Powder Is Asbestos-Free
DJ
10/29JOHNSON & JOHNSON : J&J Says Suspect Baby Powder Is Asbestos-Free
DJ
10/29JOHNSON & JOHNSON : New Tests on Baby Powder Previously Tested by FDA Found No A..
DJ
10/28JOHNSON & JOHNSON : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
10/26JOHNSON & JOHNSON : FG urged to improve school infrastructure
AQ
10/25JOHNSON & JOHNSON : Retailers pull Johnson's baby powder after recall
AQ
10/25JOHNSON & JOHNSON : FG urged to improve school infrastructure
AQ
10/24CVS HEALTH : to Halt Sales of Some J&J Talcum Powder After Recall
DJ
10/24CVS HEALTH : Pulls All 22-Ounce J&J Baby Powder From Stores -Bloomberg
DJ
10/24JOHNSON & JOHNSON : Exclusive Interview with Cedric Gysel Johnson and Johnson's ..
AQ
10/23JOHNSON & JOHNSON : J&J sets aside $4 billion for proposed opioid settlement
AQ
10/23JOHNSON & JOHNSON : Results of Operations and Financial Condition, Regulation FD..
AQ
10/23JOHNSON & JOHNSON : Thinking about trading options or stock in Apple, Boeing, Ha..
PR
10/23JOHNSON & JOHNSON : J&J's Janssen Seeks European Expansion of Tremfya for Psoria..
DJ
10/22Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombs..
RE
10/22Health Care Up as Biogen Rallies -- Health Care Roundup
DJ
10/22JOHNSON & JOHNSON : - STELARA Data Demonstrate Long-Term Efficacy and Safety Res..
AQ
10/22JOHNSON & JOHNSON : Janssen Announces U.S. FDA Approval of STELARA for the Treat..
AQ
10/22PROVENTION BIO : Says Crohn's Disease Treatment Misses Primary Endpoint
DJ
10/22JOHNSON & JOHNSON : US baby powder recall not related to products in Philippines..
AQ
10/22JOHNSON & JOHNSON : Janssen Announces U.S. FDA Approval of STELARA ® (ustekinuma..
PU
10/22Opioid Deal Lifts Odds for Broader Accord -- WSJ
DJ
10/21Drug firms avert landmark opioid trial as talks on $48 billion settlement set..
RE
10/21Drug firms avert landmark opioid trial as talks on $48-billion settlement set..
RE
10/21October brings losses for short sellers in U.S. opioid-related shares
RE
10/21Billion-dollar lawsuits accuse drugmakers, distributors of fueling U.S. opioi..
RE
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on JOHNSON & JOHNSON